Chief Medical Officer · Lexeo Therapeutics, Inc. · Common Stock
Side
SELL
Value
$99K
Shares
22.3K
Price
$4.42
Executed
Jul 1, 2026
Disclosed
Jul 1, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Jul 1 executedJul 1, 2026 disclosed
LXEO · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Bhalla Narinder Pal filed this Form 4 reporting a open-market sale of LXEO on Jul 1, 2026. It became public on Jul 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Medical Officer
Bhalla Narinder Palcik:0002109299
Issuer
Lexeo Therapeutics, Inc.cik:0001907108
Revision history · 0
No field has changed since this record was first ingested.
